218 related articles for article (PubMed ID: 1707092)
1. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
Gerfen CR; McGinty JF; Young WS
J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
[TBL] [Abstract][Full Text] [Related]
2. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study.
Gerfen CR; Young WS
Brain Res; 1988 Sep; 460(1):161-7. PubMed ID: 2464402
[TBL] [Abstract][Full Text] [Related]
3. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum.
Steiner H; Gerfen CR
J Neurosci; 1993 Dec; 13(12):5066-81. PubMed ID: 7504719
[TBL] [Abstract][Full Text] [Related]
4. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
Jiang HK; McGinty JF; Hong JS
Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
[TBL] [Abstract][Full Text] [Related]
6. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
Frau L; Morelli M; Simola N
Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
[TBL] [Abstract][Full Text] [Related]
7. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
[TBL] [Abstract][Full Text] [Related]
8. Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia.
Salin P; Hajji MD; Kerkerian-le Goff L
Eur J Neurosci; 1996 Aug; 8(8):1746-57. PubMed ID: 8921265
[TBL] [Abstract][Full Text] [Related]
9. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
[TBL] [Abstract][Full Text] [Related]
10. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
[TBL] [Abstract][Full Text] [Related]
11. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion.
Nisenbaum LK; Kitai ST; Crowley WR; Gerfen CR
Neuroscience; 1994 Jun; 60(4):927-37. PubMed ID: 7523989
[TBL] [Abstract][Full Text] [Related]
12. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
13. Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression.
Nisenbaum LK; Crowley WR; Kitai ST
Brain Res Mol Brain Res; 1996 Apr; 37(1-2):209-16. PubMed ID: 8738153
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
Li SJ; Sivam SP; McGinty JF; Jiang HK; Douglass J; Calavetta L; Hong JS
J Pharmacol Exp Ther; 1988 Jul; 246(1):403-8. PubMed ID: 2899169
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
Nisenbaum LK; Kitai ST; Gerfen CR
Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
[TBL] [Abstract][Full Text] [Related]
16. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
Carta AR; Tronci E; Pinna A; Morelli M
Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
18. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.
Carta A; Fenu S; Morelli M
Neurol Sci; 2001 Feb; 22(1):59-60. PubMed ID: 11487201
[TBL] [Abstract][Full Text] [Related]
19. Cocaine self-administration differentially alters mRNA expression of striatal peptides.
Hurd YL; Brown EE; Finlay JM; Fibiger HC; Gerfen CR
Brain Res Mol Brain Res; 1992 Mar; 13(1-2):165-70. PubMed ID: 1374504
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin.
Besson MJ; Graybiel AM; Quinn B
Neuroscience; 1990; 39(1):33-58. PubMed ID: 1708467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
